Sandwich, United Kingdom

Richard Anthony Storey

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Pfizer Corporation. Active years: 2002-2006.

USPTO Granted Patents = 4 

% Patents Active = 25.0

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Kent, GB (2002)
  • Chartham, GB (2002)
  • County of Kent, GB (2003)
  • Sandwich, GB (2006)

Company Filing History:


Years Active: 2002-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Richard Anthony Storey

Introduction

Richard Anthony Storey is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work focuses on improving processes and formulations that are essential for medical applications.

Latest Patents

Among his latest patents, Storey has developed an improved process for the preparation of a polymorph of eletriptan hemisulphate. This innovation is crucial for enhancing the efficacy of this medication. Additionally, he has created a process for the preparation of (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine, which includes intermediates and new forms suitable for pharmaceutical use, such as the zwitterion monohydrate of (I).

Career Highlights

Storey is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to groundbreaking advancements in drug development and formulation.

Collaborations

Throughout his career, Storey has collaborated with esteemed colleagues, including Laurence James Harris and Albert Shaw Wood. These partnerships have fostered innovation and have been instrumental in the success of his projects.

Conclusion

Richard Anthony Storey exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect his commitment to advancing medical science and improving patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…